The Patent Finder

IL-22 Fc FUSION PROTEINS

Genentech, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 8 of these applications claim priority to application 14/214,161, filed Mar 14, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,815,880IL-22 Fc FUSION PROTEINS
In force
 · High confidence
Genentech, Inc.In force
High confidence
US 10,087,227NUCLEIC ACIDS ENCODING IL-22 Fc FUSION PROTEINS
In force
 · High confidence
Genentech, Inc.In force
High confidence
US 10,544,198Methods of Accelerating or Improving Wound Healing Using IL-22 FC Fusion Proteins
In force
 · High confidence
Genentech, Inc.In force
High confidence
US 10,584,155PHARMACEUTICAL COMPOSITIONS OF IL-22 Fc FUSION PROTEINS
In force
 · High confidence
Genentech, Inc.In force
High confidence
US 11,332,507IL-22 Fc FUSION PROTEINS
In force
 · Medium confidence
Genentech, Inc.In force
Medium confidence
US 11,155,591METHODS OF TREATING ACUTE PANCREATITIS USING IL-22 Fc FUSION PROTEINS
In force
 · High confidence
Genentech, Inc.In force
High confidence
US 11,130,791METHODS FOR TREATING METABOLIC SYNDROME USING IL-22 Fc FUSION PROTEINS
In force
 · High confidence
Genentech, Inc.In force
High confidence
US 11,136,365METHODS FOR PREVENTING OR TREATING CARDIOVASCULAR CONDITIONS USING IL-22 Fc FUSION PROTEINS
In force
 · High confidence
Genentech, Inc.In force
High confidence
US 10,160,793METHODS OF TREATING INFLAMMATORY BOWEL DISEASE USING IL-22 Fc FUSION PROTEINS
In force
 · High confidence
F. Hoffmann-La Roche AGIn force
High confidence
Application 15/276,511IL-22 Fc FUSION PROTEIN AND METHODS OF USE
Abandoned
Abandoned May 9, 2017
Genentech, Inc.AbandonedAbandoned May 9, 2017
6 more patents in this group · Pro
10 of 16 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 16.
Upgrade to Pro
8 of these are in force and held by Genentech, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited